EOG Resources Inc vs McKesson Corporation — how do they compare? EOG Resources Inc trades at $148.4 (market cap $75.64B), while McKesson Corporation trades at $921.5 (market cap $106.14B). The key difference: McKesson Corporation is the larger of the two by market cap, and EOG Resources Inc pays the higher dividend (2.83%). Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and McKesson Corporation for 74 Days on average.
| EOG | MCK | |
|---|---|---|
Market Cap | $75.64B | $106.14B |
Volume | 2,041,336 | 794,405 |
Sector | Energy | Health |
52-Week High | $153.74 | $995.69 |
52-Week Low | $101.78 | $725.17 |
Typical Hold Time | 59 Days | 74 Days |
Enterprise Value | $78.99B | $112.67B |
Dividend Yield | 2.83% | 0.41% |
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $148.51, up 2.93% today, with a bullish technical signal from moving averages and strong fundamental metrics including a P/E of 11.22 and net income margin of 25.81%. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.07 exceeding expectations. Recent news highlights robust operational execution and disciplined capital allocation, with a CFO transition announced in September 2026.
Outlook remains positive with a consensus price target of $164.77, offering ~11% upside. Key opportunities include 5% oil volume growth guidance and strong free cash flow generation. Risks involve oil price volatility, as seen in recent price retreats, and execution of leadership transition. The stock presents a compelling value with no sell ratings among 66 analysts.
McKesson (MCK) trades at $930.25, up 0.93% with strong bullish momentum after recent earnings beats and positive news flow. The stock shows robust technical strength with moving averages signaling bullish alignment and price trading near resistance at $926. Fundamentally, revenue growth accelerated to $359.1 billion in 2025 with consistent profitability, though thin margins remain a characteristic of the distribution business model. Recent catalyst includes the CVS Health partnership extension through 2032, reinforcing long-term revenue visibility.
Outlook remains positive with 81% analyst buy ratings and $956.43 consensus target suggesting 2.8% upside. Key opportunities include oncology/GLP-1 growth drivers and operational efficiency gains, while risks center on drug pricing pressure, policy uncertainty, and competitive threats. The company's improved cash flow generation and debt reduction support financial stability amid sector headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →